New injection offers hope for uncontrollable eye blinking
NCT ID NCT07489430
First seen May 05, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study tests a drug called DaxibotulinumtoxinA (DAXI) for adults with blepharospasm, a condition that causes uncontrollable blinking or eye muscle spasms. Twenty participants will receive DAXI injections for up to 12 months to see how long the effects last and how safe it is. The goal is to provide real-world information on managing this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEPHAROSPASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parkinson Disease and Movement Disorders Center at the University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.